NOX 5.71% 6.6¢ noxopharm limited

There are a number of things I particularly like about the IONIC...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    There are a number of things I particularly like about the IONIC trial:

    • IONIC is a study involving both NOX and Bristol-Myers Squibb
    • Cohort 1 will have recently failed Opdivo – any improvement should be quickly apparent and will be due to Veyonda
    • Cohort 2 will be unsuitable for Opdivo – any response will prove that Veyonda can restore the immune function in all tumours
    • Veyonda will be used at higher dosages than in earlier trials
    • As Veyonda plus Opdivo could threaten the position of Keytruda, I imagine that Merck will closely watch developments
    • In an ideal world, BMS and Merck would get into a bidding war.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
-0.004(5.71%)
Mkt cap ! $19.28M
Open High Low Value Volume
7.6¢ 7.6¢ 6.6¢ $3.396K 49.28K

Buyers (Bids)

No. Vol. Price($)
2 57227 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 11999 1
View Market Depth
Last trade - 10.52am 05/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.